203 related articles for article (PubMed ID: 21693629)
21. Characterization of Dahl salt-sensitive rats with genetic disruption of the A2B adenosine receptor gene: implications for A2B adenosine receptor signaling during hypertension.
Nayak S; Khan MA; Wan TC; Pei H; Linden J; Dwinell MR; Geurts AM; Imig JD; Auchampach JA
Purinergic Signal; 2015 Dec; 11(4):519-31. PubMed ID: 26385692
[TBL] [Abstract][Full Text] [Related]
22. Adenosine inhibits neutrophil vascular endothelial growth factor release and transendothelial migration via A2B receptor activation.
Wakai A; Wang JH; Winter DC; Street JT; O'Sullivan RG; Redmond HP
Shock; 2001 Apr; 15(4):297-301. PubMed ID: 11303729
[TBL] [Abstract][Full Text] [Related]
23. Lysophosphatidylcholine modulates neutrophil oxidant production through elevation of cyclic AMP.
Lin P; Welch EJ; Gao XP; Malik AB; Ye RD
J Immunol; 2005 Mar; 174(5):2981-9. PubMed ID: 15728511
[TBL] [Abstract][Full Text] [Related]
24. Activation and priming of neutrophil nicotinamide adenine dinucleotide phosphate oxidase and phospholipase A(2) are dissociated by inhibitors of the kinases p42(ERK2) and p38(SAPK) and by methyl arachidonyl fluorophosphonate, the dual inhibitor of cytosolic and calcium-independent phospholipase A(2).
Mollapour E; Linch DC; Roberts PJ
Blood; 2001 Apr; 97(8):2469-77. PubMed ID: 11290612
[TBL] [Abstract][Full Text] [Related]
25. Estradiol inhibits fMLP-induced neutrophil migration and superoxide production by upregulating MKP-2 and dephosphorylating ERK.
Zhang P; Fu Y; Ju J; Wan D; Su H; Wang Z; Rui H; Jin Q; Le Y; Hou R
Int Immunopharmacol; 2019 Oct; 75():105787. PubMed ID: 31401382
[TBL] [Abstract][Full Text] [Related]
26. Contributions of A2A and A2B adenosine receptors in coronary flow responses in relation to the KATP channel using A2B and A2A/2B double-knockout mice.
Sanjani MS; Teng B; Krahn T; Tilley S; Ledent C; Mustafa SJ
Am J Physiol Heart Circ Physiol; 2011 Dec; 301(6):H2322-33. PubMed ID: 21949117
[TBL] [Abstract][Full Text] [Related]
27. Dissociations in the effects of β2-adrenergic receptor agonists on cAMP formation and superoxide production in human neutrophils: support for the concept of functional selectivity.
Brunskole Hummel I; Reinartz MT; Kälble S; Burhenne H; Schwede F; Buschauer A; Seifert R
PLoS One; 2013; 8(5):e64556. PubMed ID: 23741338
[TBL] [Abstract][Full Text] [Related]
28. The effects of Bruton tyrosine kinase inhibition on chemotaxis and superoxide generation in human neutrophils.
Broides A; Hadad N; Levy J; Levy R
J Clin Immunol; 2014 Jul; 34(5):555-60. PubMed ID: 24771458
[TBL] [Abstract][Full Text] [Related]
29. Phospholipase D-dependent and -independent p38MAPK activation pathways are required for superoxide production and chemotactic induction, respectively, in rat neutrophils stimulated by fMLP.
Azuma Y; Kosaka K; Kashimata M
Eur J Pharmacol; 2007 Jul; 568(1-3):260-8. PubMed ID: 17560994
[TBL] [Abstract][Full Text] [Related]
30. Two new formylated peptides able to activate chemotaxis and respiratory burst selectively as tools for studying human neutrophil responses.
Ferretti ME; Spisani S; Pareschi MC; Buzzi M; Cavallaro R; Traniello S; Reali E; Torrini I; Paradisi MP; Zecchini GP
Cell Signal; 1994 Jan; 6(1):91-101. PubMed ID: 7516692
[TBL] [Abstract][Full Text] [Related]
31. (2R,3R)-2-(3',4'-dihydroxybenzyl)-3-(3'',4''-dimethoxybenzyl)butyrolactone suppresses fMLP-induced superoxide production by inhibiting fMLP-receptor binding in human neutrophils.
Huang YJ; Chen IS; Tseng CP; Day YJ; Lin YC; Liao CH
Biochem Pharmacol; 2008 Feb; 75(3):688-97. PubMed ID: 17988652
[TBL] [Abstract][Full Text] [Related]
32. Adenosine A₂B receptor agonism inhibits neointimal lesion development after arterial injury in apolipoprotein E-deficient mice.
Bot I; de Vries H; Korporaal SJ; Foks AC; Bot M; van Veldhoven J; Ter Borg MN; van Santbrink PJ; van Berkel TJ; Kuiper J; Ijzerman AP
Arterioscler Thromb Vasc Biol; 2012 Sep; 32(9):2197-205. PubMed ID: 22743060
[TBL] [Abstract][Full Text] [Related]
33. Inhibition of superoxide production and chemotaxis by methotrexate in neutrophils primed by TNF-alpha or LPS.
Okuda A; Kubota M; Watanabe K; Sawada M; Koishi S; Kataoka A; Usami I; Lin YW; Furusho K
Eur J Haematol; 1997 Sep; 59(3):142-7. PubMed ID: 9310121
[TBL] [Abstract][Full Text] [Related]
34. Receptor blockade as a mechanism of deactivation of human neutrophils by pepstatin and formyl-Met-Leu-Phe.
Spilberg I; Mehta J; Muniain MA; Simchowitz L; Atkinson J
Inflammation; 1984 Mar; 8(1):73-86. PubMed ID: 6325345
[TBL] [Abstract][Full Text] [Related]
35. Adenosine promotes neutrophil chemotaxis.
Rose FR; Hirschhorn R; Weissmann G; Cronstein BN
J Exp Med; 1988 Mar; 167(3):1186-94. PubMed ID: 2832507
[TBL] [Abstract][Full Text] [Related]
36. Adenosine inhibits fMLP-stimulated adherence and superoxide anion generation by human neutrophils at an early step in signal transduction.
Burkey TH; Webster RO
Biochim Biophys Acta; 1993 Feb; 1175(3):312-8. PubMed ID: 8382084
[TBL] [Abstract][Full Text] [Related]
37. Splitomicin inhibits fMLP-induced superoxide anion production in human neutrophils by activate cAMP/PKA signaling inhibition of ERK pathway.
Liu FC; Day YJ; Liou JT; Yu HP; Liao HR
Eur J Pharmacol; 2012 Aug; 688(1-3):68-75. PubMed ID: 22634165
[TBL] [Abstract][Full Text] [Related]
38. Investigation of the cellular mechanism of inhibition of formyl-methionyl-leucyl-phenylalanine-induced superoxide anion generation in rat neutrophils by 2-benzyloxybenzaldehyde.
Wang JP; Chang LC; Lin YL; Hsu MF; Chang CY; Huang LJ; Kuo SC
Biochem Pharmacol; 2003 Apr; 65(7):1043-51. PubMed ID: 12663040
[TBL] [Abstract][Full Text] [Related]
39. Adenosine and related compounds counteract tumor necrosis factor-alpha inhibition of neutrophil migration: implication of a novel cyclic AMP-independent action on the cell surface.
Sullivan GW; Linden J; Hewlett EL; Carper HT; Hylton JB; Mandell GL
J Immunol; 1990 Sep; 145(5):1537-44. PubMed ID: 2166764
[TBL] [Abstract][Full Text] [Related]
40. Rebamipide suppresses formyl-methionyl-leucyl-phenylalanine (fMLP)-induced superoxide production by inhibiting fMLP-receptor binding in human neutrophils.
Nagano C; Azuma A; Ishiyama H; Sekiguchi K; Imagawa K; Kikuchi M
J Pharmacol Exp Ther; 2001 Apr; 297(1):388-94. PubMed ID: 11259567
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
